For over 40 years, JDRF has been a global leader in the search for an end to type 1 diabetes (T1D), through both research funding and advocacy. During that time, we have always talked about a cure as a singular destination: a return to normal physiology.
But today, we realize that we are engaged in a process of curing T1D – that a cure is not just a destination but also a journey along a path. And we recognize that a part of our mission must be to help those living with T1D today to live healthier, easier, and safer lives until we arrive at the end of that path.
JDRF'S RESEARCH GOALS
JDRF’s research is committed to improving the lives of every person with T1D and to curing this disease. JDRF's research goals are realized by the projects being supported in three basic areas: Cure, Treat, Prevent
- Cure therapies (Restoring a person’s insulin-producing capability and halting or reversing the body’s misguided immune attack on the pancreas);
- Treatment therapies (Developing new devices and therapies that transform the way people with T1D treat the disease today in order to help them live healthier lives now and in the future); and,
- Preventive therapy research (Keeping future generations from getting T1D or stopping the disease process before it damages the pancreas).
These therapeutic areas are a bold step in our promise to move the diabetes research landscape towards a cure as soon as possible. It is based on the progress and success of research over the past four decades in uncovering the most promising pathways to a cure.